Lianne Henthorn

机构：AstraZeneca (United Kingdom)

发表论文 2 篇 · 总被引 636 次 · h-index 2

代表论文

• Studies leading to the identification of ZD1839 (iressa™): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer (2001 · Bioorganic & Medicinal Chemistry Letters · 被引 570)
• ZD1839, AN EPIDERMAL GROWTH FACTOR TYROSINE KINASE INHIBITOR SELECTED FOR CLINICAL DEVELOPMENT (1997 · Journal of Immunotherapy · 被引 66)